期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

中药逆转肿瘤多药耐药的研究进展 被引量：2

The research advance of traditional Chinese medicine to reverse the tumor multidrug resistance
下载PDF
导出
摘要 目的综述逆转肿瘤多药耐药(MDR)的研究进展。方法检索中药提取物或中药单体联合化疗药物逆转肿瘤MDR的研究。结果一些中药提取物或中药单体能使耐药株对化疗药物变得敏感,使耐药蛋白的转运活性下降。结论中药具有逆转肿瘤MDR的活性,其作用机制大多是与耐药相关蛋白相关的。 Objective To review the research advance about the reversal of multidrug resistance （MDR） .Methods Herbal extracts and traditional Chinese medicine combined with chemotherapy drugs to reverse MDR were analyzed .Results Some herbal extracts or traditional Chinese medicine can improve the MDR strains sensitivity to chemotherapy ,and decrease the resistance protein trans-porter activity .Conclusion Some Chinese medicine has a reversing MDR tumor activity ,and its mechanism is mostly associated with the multidrug resistance-associated protein .
作者 程涛 宋霞 马园园 姜远英 曹永兵
机构地区 福建中医药大学 中国药科大学 第二军医大学
出处 《西北药学杂志》 CAS 2014年第3期324-328,共5页 Northwest Pharmaceutical Journal
关键词 中药 多药耐药逆转 P糖蛋白 多药耐药结合蛋白1 乳腺癌耐药蛋白 traditional Chinese medicine multidrug resistance（MDR） reversal P-glycoprotein（P gp） multidrug resistance protein1 （MRP1） breast cancer resistance protein（BCRP）
分类号 R282 [医药卫生—中药学]
  • 相关文献

参考文献39

  • 1曾嵘,周知午,吴翠芳,周于禄.芦荟大黄素脂质体逆转人肺腺癌细胞A549／DDP对顺铂多药耐药的作用研究[J].中国中药杂志,2008,33(12):1443-1445. 被引量：13
  • 2Takara K, Sakaeda T,Okumura K. An update on over coming MDRl-mediated multidrug resistance in cancer chemotherapy [J]. Curt Pharm Des,2006,12(3):273- 286.
  • 3Hai-ya Huang, Jiang-long Niu, Li-ming Zhao, et al. Reversal effeet of 2', 4'-dihydroxy-6'-methoxy 3' , 5'- dimethylchalcone on multi drug resistance in resistant human hepatocellular carcinoma cell Line BEL-7402/5- FU[J]. Phytomedicine, 2011,18 : 1086-1092.
  • 4Tomris Ozben. Mechanisms and strategies to overcome multiple drug resistance in cancer[J]. FEBS Lett, 2006,580 : 2903-2909.
  • 5Viera Bohacova, Zdena Sulova, Ima Dovinova, et al. L1210 cells cultivated under the selection pressure of doxorubicin or vincristine express common mechanisms of multidrug resistance based on the overexpression of P-glycoprotein [J]. Toxicol in Vitro, 2006, 20 : 1560- 1568.
  • 6Tsuruo T, Naito M, Tomida A. Molecular targeting therapy of caner:drug resistance, apoptosis and survival signal [J]. Cancer Sci,2003,94(1) :15-21.
  • 7M Hennessy,J P Spiers. A primer on the mechanics of P-glycoprotein the multidrug transporter[J]. Pharma- col Res,2007,55(1) :1-15.
  • 8Kaspar P Locher. Structure and mechanism of ATP- binding cassette transporters[J]. Phil Trans R Soe B, 2009,364 : 239-245.
  • 9Till Krech, Elisa Scheuerer, Robert Geffers, et al. AB- CB1/MDR1 contributes to the anticancer drug-resistant phenotype of IPH-926 human lobular breast cancer cells[J]. Cancer Lett,2012,315(2) :153-160.
  • 10McDevitt C A, Callaghan R. How can we best use structural information on P-glycoprotein to design in- hibitors? [J], Pharmacol & Therapeut, 2007, 113: 429-441.

二级参考文献50

  • 1管晓翔,陈龙邦.肿瘤多药耐药性及其治疗进展[J].癌症进展,2004,2(2):120-123. 被引量：6
  • 2苏云明,郭欣,白云,黄晓峰,姜波,白海玉.芦荟抗肿瘤作用研究[J].中国药师,2006,9(6):486-488. 被引量：9
  • 3王玲,刘世坤,周于禄,裴奇.华蟾素对人乳腺癌细胞阿霉素多药耐药性的逆转作用[J].中国药理学通报,2007,23(5):677-680. 被引量：38
  • 4Bergman AM,Pinedo HM,Tallanidis 1,et al. Increased sensitivity to gemcitabine of P - glycoprotein and multi - drug resistance - associated protein -overexpressing human cancer cell lines. Br[ J ]. Cancer,2003,88(12) : 1963.
  • 5van der Pol MA,Broxterman HJ,Paler JM,et at. Function of the ABC transporters, P - gtycoprotein, muhidrug resistance protein and breast cancer resistance protein,inminimal residual disease in acute myeloid leukemia [ J ]. Haematologica, 2003,88 (2) :134 - 147.
  • 6Gruber A,Bjorkholm M,Brinch L,et at. A phase I/ll study of the MDR modulator Valspodar( PSC833 ) combined with daunorubicin and cytarabine in patients withrelapsed and primary refi'actory acute myeloid leukemia[ J]. Leuk Res ,2003,27:323 - 328.
  • 7Cruz F, Wolf A. Effects of the novel cyclosporine derivative PSC833 on glucose metabolism in rat primary cultures of neuronaland filial cells[J]. Biochem Phannacol,2001,62( 1 ) :129.
  • 8Jin J ,Wang FP,Wei H,Liu G. Reversal of muhidrug resistance of cancer through inhibition of P, glycoprotein by 5 - bromotctran- drine[ J]. Cancer Chemother Phannacol,2008,55 (2) :179.
  • 9Ghetie MA, Marches R, Kufert S, Vitetta ES. An anti - CD19 anti- body inhibits the interaction between P - glycoprotein( P - gp) and CD19, causes P - gp to translocate out of lipid rafts,and chemosensitizes a multidrug - resistant ( MDR ) lymphoma cell line [ J ]. Blood ,2004,104( 1 ) :178.
  • 10Yuko H, Aftra F, Yves P, et al Differential cytotoxicity of clinically important camptothecin derivatives in P - glyeoprotein overexpressing cell lines [ J ]. Cancer Chemother Phamnaeol, 1997,40 ( 5 ) : 433.

共引文献19

同被引文献25

引证文献2

二级引证文献22

西北药学杂志
2014年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部